Brian Godman
Brian Godman
Karolinska Institute, Strathclyde Institute of Pharmacy and Biomedical Sciences
Verified email at briangodman.co.uk
Title
Cited by
Cited by
Year
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
J Adamski, B Godman, G Ofierska-Sujkowska, B Osińska, H Herholz, ...
BMC health services research 10 (1), 1-16, 2010
2702010
The ‘wise list’–a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm
LL Gustafsson, B Wettermark, B Godman, E Andersén‐Karlsson, ...
Basic & clinical pharmacology & toxicology 108 (4), 224-233, 2011
2412011
Economics of myocardial perfusion imaging in Europe—the EMPIRE Study
SR Underwood, B Godman, S Salyani, JR Ogle, PJ Ell
European heart journal 20 (2), 157-166, 1999
2181999
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ...
Expert review of pharmacoeconomics & outcomes research 10 (6), 707-722, 2010
1792010
Efficacy of mobile apps to support the care of patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
BC Bonoto, VE de Araújo, IP Godói, LLP de Lemos, B Godman, M Bennie, ...
JMIR mHealth and uHealth 5 (3), e4, 2017
1722017
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ...
Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009
1602009
Policies for biosimilar uptake in Europe: an overview
E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ...
PloS one 12 (12), e0190147, 2017
1562017
Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature
RS Md Rezal, MA Hassali, AA Alrasheedy, F Saleem, FA Md Yusof, ...
Expert review of anti-infective therapy 13 (5), 665-680, 2015
1532015
Ongoing pharmaceutical reforms in France
C Sermet, V Andrieu, B Godman, E Van Ganse, A Haycox, JP Reynier
Applied health economics and health policy 8 (1), 7-24, 2010
1402010
Policies to enhance prescribing efficiency in Europe: findings and future implications
B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ...
Frontiers in pharmacology 1, 141, 2011
1332011
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
B Godman, RE Malmström, E Diogene, A Gray, S Jayathissa, A Timoney, ...
Expert review of clinical pharmacology 8 (1), 77-94, 2015
1322015
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
B Godman, B Wettermark, M Van Woerkom, J Fraeyman, ...
Frontiers in pharmacology 5, 106, 2014
1282014
Use of generics—a critical cost containment measure for all healthcare professionals in Europe?
B Godman, W Shrank, B Wettermark, M Andersen, I Bishop, T Burkhardt, ...
Pharmaceuticals 3 (8), 2470-2494, 2010
1122010
Recent national and regional drug reforms in Sweden
B Wettermark, B Godman, K Andersson, LL Gustafsson, A Haycox, ...
Pharmacoeconomics 26 (7), 537-550, 2008
1082008
Personalizing health care: feasibility and future implications
B Godman, AE Finlayson, PK Cheema, E Zebedin-Brandl, ...
BMC medicine 11 (1), 1-23, 2013
1072013
Soft regulations in pharmaceutical policy making
B Wettermark, B Godman, B Jacobsson, FM Haaijer-Ruskamp
Applied health economics and health policy 7 (3), 137-147, 2009
1072009
Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study
JC Meyer, N Schellack, J Stokes, R Lancaster, H Zeeman, D Defty, ...
Frontiers in pharmacology 8, 751, 2017
1052017
Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland
M Bennie, B Godman, I Bishop, S Campbell
Expert review of pharmacoeconomics & outcomes research 12 (1), 125-130, 2012
1032012
Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
R Malmstrom, B Godman, E Diogene, C Baumgärtel, M Bennie, I Bishop, ...
Frontiers in pharmacology 4, 39, 2013
982013
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries
B Godman, I Bishop, AE Finlayson, S Campbell, HY Kwon, M Bennie
Expert review of pharmacoeconomics & outcomes research 13 (4), 469-482, 2013
922013
The system can't perform the operation now. Try again later.
Articles 1–20